Financial Management Network Inc Sarepta Therapeutics, Inc. Transaction History
Financial Management Network Inc
- $471 Million
- Q2 2025
Shares
4 transactions
Others Institutions Holding SRPT
# of Institutions
462Shares Held
83.3MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$231 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$205 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$105 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$100 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$56.6 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.96B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...